procedure growth

2 articles
BenzingaBenzinga··Lekha Gupta

Intuitive Surgical Beats Q1 Estimates But Battles Regional Headwinds

Intuitive Surgical beat Q1 earnings estimates with $2.77B revenue and $2.50 EPS, raising Da Vinci guidance. Stock up 2.13% despite Asia weakness and bariatric procedure declines.
ISRGIGPTBOTZinternational expansiongross margin
The Motley FoolThe Motley Fool··Daniel Sparks

Intuitive Surgical Faces Valuation Crossroads After Strong Q4 Results

Intuitive Surgical posted strong Q4 results with 19% revenue growth, but 2026 guidance signals meaningful deceleration. At 63x earnings, stock appears fairly valued for current shareholders but overvalued for new investors.
ISRGmedical devicesvaluation risk